About P&T JournalContacts:
Editorial: Sonja Sherritze, Editor
Advertising: Maureen Dwyer Liberti,
Vice President, Group Publisher
Production: Mary Ellen Curry,
Director of Production Services
Circulation: Jackie Ott, Circulation Manager
Statement of Purpose
Guidelines for Authors
Dr. Goldenberg presents the latest labeling changes for atorvastatin (Lipitor®), risperidone (Risperdal®), Gynecare Intergel Adhesion Prevention Solution® to heal adhesions after gynecological surgery, and lindane (Kwell®) to treat lice and scabies.
Marvin M. Goldenberg, PhD, RPh, MS
Dr. Cunha describes natural and acquired resistance to antimicrobial agents and effective strategies to control this growing problem.
Burke A. Cunha, MD
Dr. Prescott discusses advances in the treatment of breast, pancreatic, and colorectal cancers; bronchoalveolar cell carcinoma; refractory cancers; melanoma; non-Hodgkin’s lymphoma; leukemia; and chemotherapy-induced anemia.
Lawrence M. Prescott, PhD
Continuing Education Credit
The authors review the armamentarium of medications used to treat AIDS and HIV infection.
Eli Korner, PharmD, MPH, Mary Ellen Bonk, PharmD, Thomas Ratko, PhD, and Karl Matuszewski, MS, PharmD
Editor-in-Chief David Nash, MD, MBA, translates some new acronyms used in drug coverage under Medicare: LMRP, CAC, and NCD.
David B. Nash, MD, MBA
Matthew Grissinger discusses ways to measure the effectiveness and safety of medication use.
Stephen Barlas describes possible changes in Medicare’s reimbursements to hospitals with pharmacist residency programs.
P&T presents the latest information about approvals, indication changes, industry updates, and news from the FDA.
Drs. Mack and Neely review adalimumab (Humira®) for the treatment of rheumatoid arthritis.
Alicia Mack, PharmD, and Jessica Neely, PharmD